FI943376A0 - Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina - Google Patents

Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina

Info

Publication number
FI943376A0
FI943376A0 FI943376A FI943376A FI943376A0 FI 943376 A0 FI943376 A0 FI 943376A0 FI 943376 A FI943376 A FI 943376A FI 943376 A FI943376 A FI 943376A FI 943376 A0 FI943376 A0 FI 943376A0
Authority
FI
Finland
Prior art keywords
hydrogen
alkyl
derivatives
phenylimidazolidinone
preparation
Prior art date
Application number
FI943376A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943376A (fi
Inventor
Mario Varasi
Franco Heidempergher
Carla Caccia
Claudio Arrigoni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI943376A0 publication Critical patent/FI943376A0/fi
Publication of FI943376A publication Critical patent/FI943376A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI943376A 1992-11-18 1994-07-15 Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina FI943376A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224144A GB9224144D0 (en) 1992-11-18 1992-11-18 Phenyl-imidazolidinone derivatives and process for their preparation
PCT/EP1993/002924 WO1994011347A1 (en) 1992-11-18 1993-10-22 Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists

Publications (2)

Publication Number Publication Date
FI943376A0 true FI943376A0 (fi) 1994-07-15
FI943376A FI943376A (fi) 1994-07-15

Family

ID=10725269

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943376A FI943376A (fi) 1992-11-18 1994-07-15 Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina

Country Status (19)

Country Link
US (1) US5424328A (hu)
EP (1) EP0623114B1 (hu)
JP (1) JP3794696B2 (hu)
CN (1) CN1093702A (hu)
AT (1) ATE179701T1 (hu)
AU (1) AU666793B2 (hu)
CA (1) CA2127536C (hu)
DE (1) DE69324794T2 (hu)
ES (1) ES2133415T3 (hu)
FI (1) FI943376A (hu)
GB (1) GB9224144D0 (hu)
HU (1) HUT70395A (hu)
IL (1) IL107371A (hu)
NZ (1) NZ257117A (hu)
PL (1) PL174416B1 (hu)
RU (1) RU2126403C1 (hu)
TW (1) TW233297B (hu)
WO (1) WO1994011347A1 (hu)
ZA (1) ZA938206B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780492A (en) * 1996-04-03 1998-07-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6455424B1 (en) * 2000-08-07 2002-09-24 Micron Technology, Inc. Selective cap layers over recessed polysilicon plugs
US9181261B2 (en) * 2012-05-22 2015-11-10 Merck Sharp & Dohme Corp. TrkA kinase inhibitors, compositions and methods thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459757A (en) * 1965-10-22 1969-08-05 American Cyanamid Co Imidazolidines
US3491098A (en) * 1967-05-29 1970-01-20 Sterling Drug Inc 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines
US3702327A (en) * 1970-12-28 1972-11-07 Aldrich Chem Co Inc N-beta-1-(3-phenylimidazolidin-2-one)ethyl 4,4-ethylene dioxypiperidines
JPS6133172A (ja) * 1984-07-24 1986-02-17 Kotobuki Seiyaku Kk 1,3−置換−2−イミダゾリジノン誘導体,胃腸運動亢進剤及びその製造方法
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
FI90869C (fi) * 1986-11-14 1994-04-11 Tanabe Seiyaku Co Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi
IE63474B1 (en) * 1987-12-24 1995-04-19 Wyeth John & Brother Ltd Heterocyclic compounds
IT1230703B (it) * 1989-01-26 1991-10-29 Luso Farmaco Inst Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
GB2248058B (en) * 1990-09-21 1994-09-14 Orion Yhtymae Oy Aromatase inhibiting 4(5)-imidazoles
GB9106571D0 (en) * 1991-03-27 1991-05-15 Erba Carlo Spa Derivatives of substituted imidazol-2-one and process for their preparation
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
IT1255802B (it) * 1992-08-07 1995-11-16 Luso Farmaco Inst Derivati imidazolici ad attivita' a ii antagonista

Also Published As

Publication number Publication date
ZA938206B (en) 1994-06-10
ATE179701T1 (de) 1999-05-15
TW233297B (hu) 1994-11-01
EP0623114A1 (en) 1994-11-09
JP3794696B2 (ja) 2006-07-05
IL107371A (en) 1998-02-08
CA2127536C (en) 2005-09-06
GB9224144D0 (en) 1993-01-06
DE69324794T2 (de) 1999-12-02
US5424328A (en) 1995-06-13
JPH07503256A (ja) 1995-04-06
DE69324794D1 (de) 1999-06-10
IL107371A0 (en) 1994-01-25
CN1093702A (zh) 1994-10-19
EP0623114B1 (en) 1999-05-06
RU2126403C1 (ru) 1999-02-20
PL174416B1 (pl) 1998-07-31
RU94036775A (ru) 1996-05-27
PL304676A1 (en) 1995-01-09
AU666793B2 (en) 1996-02-22
AU5336494A (en) 1994-06-08
CA2127536A1 (en) 1994-05-26
HU9401948D0 (en) 1994-09-28
FI943376A (fi) 1994-07-15
HUT70395A (en) 1995-10-30
ES2133415T3 (es) 1999-09-16
NZ257117A (en) 1995-08-28
WO1994011347A1 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
EG20280A (en) Process for preparing of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
GR3026231T3 (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles.
SI0773943T1 (en) Compounds useful as antiproliferative agents and garft inhibitors
PL308669A1 (en) Derivatives of 5-aryloindole and their application as (5-ht 1) antagonists of serotonine
NZ515408A (en) 5-phenyl-pyrimidine derivatives
GB9806692D0 (en) Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
HUT68056A (en) Substituted indoles and azaindoles as angiotensin ii antagonists, pharmaceutical compositions containing same, process for their production and intermediates
GB9306886D0 (en) Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
YU22099A (sh) Dobijanje supstituisanih piridina
HUP0000321A2 (hu) NOS inhibitor hatású aromás aminszármazékok, eljárás előállításukra, valamint a vegyületeket tartalmazó gyógyszerkészítmények
FI943376A0 (fi) Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina
FI921308A (fi) Foerfarande foer framstaellning av derivat av substituerad imidazol-2-on
DE69430618D1 (de) Cephemverbindungen
GB9306899D0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
AU5674894A (en) Azanoradamantanes
AU7458894A (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
ES2056025A1 (es) Nuevos derivados de indol.
NO308304B1 (no) Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.

FD Application lapsed